Skip to search formSkip to main contentSkip to account menu

lacidipine

Known as: diethyl 2,6-dimethyl-4-(2-((E)-2-((2-methylpropan-2-yl)oxycarbonyl)ethenyl)phenyl)-1,4-dihydropyridine-3,5-dicarboxylate, lacidipine [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The aim of present study was to develop the Lacidipine oral disintegrating tablets (LCDP ODTs), thereby enhancing the solubility… 
2012
2012
In this study, we investigated the effects of lacidipine on XO, MDA, MPO, and GSH levels in ovarian tissues of rats, which are… 
2010
2010
The aim of this study was to develop and optimize SNEDDS formulations containing surfactants reported to be bioenhancers for… 
2008
2008
Lacidipine, a newly developed, 1,4-dihydropyridine derivative with potent and long lasting antihypertensive activity was… 
1995
1995
Lacidipine,a new 1,4-dihydropyridine calcium channel blocker, is effective in the treatment of essential hypextension. The… 
1994
1994
We studied the effects of two antagonist dihydropyridines (DHPs) on calcium currents in cultured pituitary GH3 cells by the… 
1993
1993
SummaryVascular selectivity of lacidipine, a new potent and long-acting coronary vasodilator, was evaluated by a comparison with… 
Review
1993
Review
1993
Aim: To review the effects of calcium antagonists, and of the new dihydropyridine lacidipine in particular, on the glomerular… 
Review
1993
Review
1993
  • L. Hansson
  • 1993
  • Corpus ID: 5951415
Recent clinical trials in the elderly: The results of three major intervention trials against hypertension in the elderly were… 
1991
1991
Summary:Thirty-one centers in the U.K. recruited 637 patients (aged 21 to 75 years) with mild-to-moderate essential hypertension…